{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MYD88",
                "DNA Alteration": "c.794T>C",
                "GeneMutation": "p.L265P Spliceregionvariant-LOF",
                "VariantAlleleFraction": "11.73%"
            },
            {
                "Gene": "ERCC2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F332V Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "11.11%"
            },
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.547G>A",
                "GeneMutation": "p.P80R Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.47%"
            },
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.964G>A",
                "GeneMutation": "p.G183S Frameshift-GOF",
                "VariantAlleleFraction": "9.02%"
            },
            {
                "Gene": "H3.3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G35W Spliceregionvariant-LOF",
                "VariantAlleleFraction": "8.69%"
            },
            {
                "Gene": "HSP90B1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.I66T Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "5.96%"
            },
            {
                "Gene": "PKLR",
                "DNA Alteration": "c.1436G>A",
                "GeneMutation": "p.R479H Stopgain-LOF",
                "VariantAlleleFraction": "4.81%"
            },
            {
                "Gene": "EZH2",
                "DNA Alteration": "c.1936T>A",
                "GeneMutation": "p.Y646F Nonsense-LOF",
                "VariantAlleleFraction": "3.14%"
            }
        ],
        "Germline": [
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Missensevariant(exon2)-GOF",
                "Condition": "anyone"
            }
        ]
    }
}